Global Irritable Bowel Syndrome Treatment Drug market size is predicted to grow from US$ 3743 million in 2025 to US$ 4525 million in 2031; it is expected to grow at a CAGR of 3.2% from 2025 to 2031. Get Access Now!

Global Irritable Bowel Syndrome Treatment Drug Market Growth Status and Outlook 2025-2031

The global Irritable Bowel Syndrome Treatment Drug market size is predicted to grow from US$ 3743 million in 2025 to US$ 4525 million in 2031; it is expected to grow at a CAGR of 3.2% from 2025 to 2031. Irritable bowel syndrome (IBS) isa common condition that affects the digestive system. It causes symptoms like stomach cramps, bloating, diarrhoea and constipation. These tend to come and go over time, and can last for days, weeks or months at a time. Its usually a lifelong problem. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. LPI (LP Information) newest research report, the Irritable Bowel Syndrome Treatment Drug Industry Forecast looks at past sales and reviews total world Irritable Bowel Syndrome Treatment Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Irritable Bowel Syndrome Treatment Drug sales for 2025 through 2031. With Irritable Bowel Syndrome Treatment Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Irritable Bowel Syndrome Treatment Drug industry. This Insight Report provides a comprehensive analysis of the global Irritable Bowel Syndrome Treatment Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Irritable Bowel Syndrome Treatment Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Irritable Bowel Syndrome Treatment Drug market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Irritable Bowel Syndrome Treatment Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Irritable Bowel Syndrome Treatment Drug. This report presents a comprehensive overview, market shares, and growth opportunities of Irritable Bowel Syndrome Treatment Drug market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Antibiotics &nbsp;&nbsp;&nbsp; Amino Salicylates &nbsp;&nbsp;&nbsp; Corticosteroids &nbsp;&nbsp;&nbsp; Immunomodulators &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospitals &nbsp;&nbsp;&nbsp; Specialty Clinics &nbsp;&nbsp;&nbsp; Other This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Abbvie Inc. &nbsp;&nbsp;&nbsp; Bristol Myers Squibb &nbsp;&nbsp;&nbsp; Roche &nbsp;&nbsp;&nbsp; Johnson & Johnson &nbsp;&nbsp;&nbsp; Pfizer Inc. &nbsp;&nbsp;&nbsp; Prometheus Laboratories Inc. (Nestle) &nbsp;&nbsp;&nbsp; Bausch Health &nbsp;&nbsp;&nbsp; Takeda Pharmaceutical Ltd &nbsp;&nbsp;&nbsp; Biogen &nbsp;&nbsp;&nbsp; AstraZeneca

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Irritable Bowel Syndrome Treatment Drug Market Size (2020-2031) &nbsp;2.1.2 Irritable Bowel Syndrome Treatment Drug Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Irritable Bowel Syndrome Treatment Drug by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Irritable Bowel Syndrome Treatment Drug Segment by Type &nbsp;2.2.1 Antibiotics &nbsp;2.2.2 Amino Salicylates &nbsp;2.2.3 Corticosteroids &nbsp;2.2.4 Immunomodulators &nbsp;2.2.5 Others &nbsp;2.3 Irritable Bowel Syndrome Treatment Drug Market Size by Type &nbsp;2.3.1 Irritable Bowel Syndrome Treatment Drug Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Irritable Bowel Syndrome Treatment Drug Market Size Market Share by Type (2020-2025) &nbsp;2.4 Irritable Bowel Syndrome Treatment Drug Segment by Application &nbsp;2.4.1 Hospitals &nbsp;2.4.2 Specialty Clinics &nbsp;2.4.3 Other &nbsp;2.5 Irritable Bowel Syndrome Treatment Drug Market Size by Application &nbsp;2.5.1 Irritable Bowel Syndrome Treatment Drug Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Irritable Bowel Syndrome Treatment Drug Market Size Market Share by Application (2020-2025) 3 Irritable Bowel Syndrome Treatment Drug Market Size by Player &nbsp;3.1 Irritable Bowel Syndrome Treatment Drug Market Size Market Share by Player &nbsp;3.1.1 Global Irritable Bowel Syndrome Treatment Drug Revenue by Player (2020-2025) &nbsp;3.1.2 Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Irritable Bowel Syndrome Treatment Drug Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Irritable Bowel Syndrome Treatment Drug by Region &nbsp;4.1 Irritable Bowel Syndrome Treatment Drug Market Size by Region (2020-2025) &nbsp;4.2 Global Irritable Bowel Syndrome Treatment Drug Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Irritable Bowel Syndrome Treatment Drug Market Size Growth (2020-2025) &nbsp;4.4 APAC Irritable Bowel Syndrome Treatment Drug Market Size Growth (2020-2025) &nbsp;4.5 Europe Irritable Bowel Syndrome Treatment Drug Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Irritable Bowel Syndrome Treatment Drug Market Size by Country (2020-2025) &nbsp;5.2 Americas Irritable Bowel Syndrome Treatment Drug Market Size by Type (2020-2025) &nbsp;5.3 Americas Irritable Bowel Syndrome Treatment Drug Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Irritable Bowel Syndrome Treatment Drug Market Size by Region (2020-2025) &nbsp;6.2 APAC Irritable Bowel Syndrome Treatment Drug Market Size by Type (2020-2025) &nbsp;6.3 APAC Irritable Bowel Syndrome Treatment Drug Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Irritable Bowel Syndrome Treatment Drug Market Size by Country (2020-2025) &nbsp;7.2 Europe Irritable Bowel Syndrome Treatment Drug Market Size by Type (2020-2025) &nbsp;7.3 Europe Irritable Bowel Syndrome Treatment Drug Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Irritable Bowel Syndrome Treatment Drug by Region (2020-2025) &nbsp;8.2 Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Irritable Bowel Syndrome Treatment Drug Market Forecast &nbsp;10.1 Global Irritable Bowel Syndrome Treatment Drug Forecast by Region (2026-2031) &nbsp;10.1.1 Global Irritable Bowel Syndrome Treatment Drug Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.1.3 APAC Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.1.4 Europe Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.1.5 Middle East & Africa Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.2 Americas Irritable Bowel Syndrome Treatment Drug Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.2.2 Canada Market Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.2.3 Mexico Market Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.2.4 Brazil Market Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.3 APAC Irritable Bowel Syndrome Treatment Drug Forecast by Region (2026-2031) &nbsp;10.3.1 China Irritable Bowel Syndrome Treatment Drug Market Forecast &nbsp;10.3.2 Japan Market Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.3.3 Korea Market Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.3.4 Southeast Asia Market Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.3.5 India Market Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.3.6 Australia Market Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.4 Europe Irritable Bowel Syndrome Treatment Drug Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.4.2 France Market Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.4.3 UK Market Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.4.4 Italy Market Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.4.5 Russia Market Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.5 Middle East & Africa Irritable Bowel Syndrome Treatment Drug Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.5.2 South Africa Market Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.5.3 Israel Market Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.5.4 Turkey Market Irritable Bowel Syndrome Treatment Drug Forecast &nbsp;10.6 Global Irritable Bowel Syndrome Treatment Drug Forecast by Type (2026-2031) &nbsp;10.7 Global Irritable Bowel Syndrome Treatment Drug Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Irritable Bowel Syndrome Treatment Drug Forecast 11 Key Players Analysis &nbsp;11.1 Abbvie Inc. &nbsp;11.1.1 Abbvie Inc. Company Information &nbsp;11.1.2 Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Product Offered &nbsp;11.1.3 Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Abbvie Inc. Main Business Overview &nbsp;11.1.5 Abbvie Inc. Latest Developments &nbsp;11.2 Bristol Myers Squibb &nbsp;11.2.1 Bristol Myers Squibb Company Information &nbsp;11.2.2 Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Product Offered &nbsp;11.2.3 Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Bristol Myers Squibb Main Business Overview &nbsp;11.2.5 Bristol Myers Squibb Latest Developments &nbsp;11.3 Roche &nbsp;11.3.1 Roche Company Information &nbsp;11.3.2 Roche Irritable Bowel Syndrome Treatment Drug Product Offered &nbsp;11.3.3 Roche Irritable Bowel Syndrome Treatment Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Roche Main Business Overview &nbsp;11.3.5 Roche Latest Developments &nbsp;11.4 Johnson & Johnson &nbsp;11.4.1 Johnson & Johnson Company Information &nbsp;11.4.2 Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Product Offered &nbsp;11.4.3 Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Johnson & Johnson Main Business Overview &nbsp;11.4.5 Johnson & Johnson Latest Developments &nbsp;11.5 Pfizer Inc. &nbsp;11.5.1 Pfizer Inc. Company Information &nbsp;11.5.2 Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Product Offered &nbsp;11.5.3 Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Pfizer Inc. Main Business Overview &nbsp;11.5.5 Pfizer Inc. Latest Developments &nbsp;11.6 Prometheus Laboratories Inc. (Nestle) &nbsp;11.6.1 Prometheus Laboratories Inc. (Nestle) Company Information &nbsp;11.6.2 Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Product Offered &nbsp;11.6.3 Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Prometheus Laboratories Inc. (Nestle) Main Business Overview &nbsp;11.6.5 Prometheus Laboratories Inc. (Nestle) Latest Developments &nbsp;11.7 Bausch Health &nbsp;11.7.1 Bausch Health Company Information &nbsp;11.7.2 Bausch Health Irritable Bowel Syndrome Treatment Drug Product Offered &nbsp;11.7.3 Bausch Health Irritable Bowel Syndrome Treatment Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Bausch Health Main Business Overview &nbsp;11.7.5 Bausch Health Latest Developments &nbsp;11.8 Takeda Pharmaceutical Ltd &nbsp;11.8.1 Takeda Pharmaceutical Ltd Company Information &nbsp;11.8.2 Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Product Offered &nbsp;11.8.3 Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Takeda Pharmaceutical Ltd Main Business Overview &nbsp;11.8.5 Takeda Pharmaceutical Ltd Latest Developments &nbsp;11.9 Biogen &nbsp;11.9.1 Biogen Company Information &nbsp;11.9.2 Biogen Irritable Bowel Syndrome Treatment Drug Product Offered &nbsp;11.9.3 Biogen Irritable Bowel Syndrome Treatment Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 Biogen Main Business Overview &nbsp;11.9.5 Biogen Latest Developments &nbsp;11.10 AstraZeneca &nbsp;11.10.1 AstraZeneca Company Information &nbsp;11.10.2 AstraZeneca Irritable Bowel Syndrome Treatment Drug Product Offered &nbsp;11.10.3 AstraZeneca Irritable Bowel Syndrome Treatment Drug Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 AstraZeneca Main Business Overview &nbsp;11.10.5 AstraZeneca Latest Developments 12 Research Findings and Conclusion

Report	Global Irritable Bowel Syndrome Treatment Drug Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI35829

Buyer Information

Order Summary